News
$FibroGen(FGEN.US$ FibroGen Announces FDA Clearance Of Investigational New Drug FG-3165, A Galectin-9 Targeted Monoclonal Antibody For Treating Solid Tumors
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
